Dynavax Technologies Corp (DVAX)

[Small Time Joe]

I posted this on July 20th. Still true today.
Just playing with numbers averaging ratios of CELG and JNJ. One article says by 2021 the Hep B market could be as high as 3.5 Billion. Lets say DVAX produces 600 million of Revenue. Average profit margin of the above companies 21%. That's a 120 million dollar profit. $2 per share at 60M shares outstanding. Average P.E. of the above companies 36. So 36 times 2 we get a share price of $72. $1.5 per share at 80M shares outstanding. PE 36 times $1.5 we get a price of $54. Would the competition consider buying DVAX for this product and the rest of the pipeline. Interesting considerations, lots of green in the future I believe. GLTA.